Ovarian stimulation and borderline ovarian tumors: A case-control study

Fertility and Sterility

Volumn 70, Issue 6, 1998, Pages 1049-1055

  Mosgaard, Berit Jul ^a   Lidegaard, Øjvind ^a   Kjær, Susanne Krüger ^b   Schou, Geert ^b   Andersen, Anders Nyboe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Borderline; Case control study; Epidemiology; Fertility drugs; Infertility; Ovarian cancer; Parity

Indexed keywords

FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DENMARK; FEMALE; FEMALE INFERTILITY; HUMAN; HUMAN TISSUE; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; NULLIPARA; OVARY CANCER; OVARY HYPERSTIMULATION; PARITY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; CASE-CONTROL STUDIES; DENMARK; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; OVULATION INDUCTION; PARITY; PREVALENCE; RISK FACTORS;

EID: 0032402371     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00337-9     Document Type: Article

References (25)

1. Whittemore A.S., Harris R., Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 136:1992;1184-1203.
2. Harris R., Whittemore A.S., Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 136:1992;1204-1211.
3. Franceschi S., La Vecchia C., Negri E., Guarneri S., Montella M., Conti E., et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod. 9:1994;1673-1675.
4. Rossing M.A., Daling J.R., Weiss N.S., Moore D.E., Self S.G. Ovarian tumors in a cohort of infertile women. N Engl J Med. 331:1994;771-776.
5. Venn A., Watson L., Lumley J., Giles G., King C., Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 346:1995;995-1000.
6. Shushan A., Paltiel O., Iscovich J., Elchalal U., Peretz T., Schenker J.G. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril. 65:1996;13-18.
7. Mosgaard B.J., Lidegaard Ø., Kjær S.K., Schou G., Andersen A.N. Infertility, fertility drugs and invasive ovarian cancer a case-control study . Fertil Steril. 67:1997;1005-1012.
8. Clayton D., Hills M. Statistical methods in epidemiology. 1993;Oxford University Press, Oxford, UK.
9. Schmidt L., Münster K., Helm P. Infertility and the seeking of infertility treatment in a representative population. Br J Obstet Gynaecol. 102:1995;978-984.
10. Mosgaard B., Lidegaard O., Andersen A.N. Use of fertility drugs in Denmark 1973-1993. An analysis based on sale statistics. Acta Obstet Gynecol Scand. 95:1995;614-618.
11. Risch H.A., Marrett L.D., Jain M., Howe G.R. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol. 96:1996;363-372.
12. Harlow B.L., Weiss N.S., Roth G.J., Chu J., Daling J.R. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. Cancer Res. 48:1988;5849-5852.
13. Parazzini F., Restelli C., La Vecchia C., Negri E., Chiari S., Maggi R., et al. Risk factors for epithelial ovarian tumours of borderline malignancy. Int J Epidemiol. 20:1991;871-877.
14. Annegers J.F., Strom H., Decker D.G., Dockerty M.B., O'Fallon W.M. Ovarian cancer incidence and case-control study . Cancer. 43:1979;723-729.
15. Casagrande J.T., Louie E.W., Pike M.C., Roy S., Ross R.K., Henderson B.E. "Incessant ovulation" and ovarian cancer. Lancet. 2:1979;170-173.
16. Whittemore A.S., Wu M.L., Paffenbarger R.S. Jr, Sarles D.L., Kampert J.B., Grosser S., et al. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol. 128:1988;1228-1240.
17. Risch H.A., Marrett L.D., Howe G.R. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol. 140:1994;585-597.
18. Mori M., Harabuchi I., Miyake H., Casagrande J.T., Henderson B.E., Ross R.K. Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol. 128:1988;771-777.
19. Koch M. Risk factors in ovarian cancer of epithelial origin by pathological diagnosis. Br J Cancer. 59:1989;257-258.
20. Whittemore A.S., Harris R., Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol. 136:1992;1212-1220.
21. McGowan L. Epidemiology of ovarian cancer. Oncology (Huntingt). 3:1989;51-54.
22. Hartge P., Schiffman M.H., Hoover R., McGowan L., Lesher L., Norris H.J. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol. 161:1989;10-16.
23. Cramer D.W., Hutchison G.B., Welch W.R., Scully R.E., Ryan K.J. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst. 71:1983;711-716.
24. Nasca P.C., Greenwald P., Chorost S., Richart R., Caputo T. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol. 119:1984;705-713.
25. Shapiro S. Risk of ovarian cancer after treatment for infertility. N Engl J Med. 332:1995;1301.